Product details

Tata-owned Titan Company's EyeCare division Titan Eye+, established in 2007, was known to have pioneered prescription eyewear retail business (which remained highly fragmented) across India. The retail chain sold prescription eyewear as well as lifestyle products under brands like Titan, Titan Glares and Fastrack, besides several international brands as well as contact lenses from Bausch + Lomb, Alcon, and Johnson & Johnson. The eyewear/optical retail business which had been stagnant until 2010 had witnessed a boom with the entry of revolutionary technology, organised players, and increasing demand for eyewear as well as significant shift in preferences and changing attitudes towards the category. By 2027, the eyewear market was expected to be worth USD9.69 billion. After having logged its best-ever financial performance in FY2022, Titan Eye+ was looking forward to strengthening its retail presence targeting Generation Z population, ramping up local production, besides developing a strong local vendor base, and increasing customer awareness to position itself as an 'EyeCare' brand focusing on product innovation. While achieving scale remained a big challenge, would Titan Eye+'s bid to capture a slice of booming eyewear market pay off in the long run?